Correlation of bevacizumab relative dose intensity with first-line treatment outcomes in advanced epithelial ovarian cancer.
OBJECTIVE To evaluate the association between bevacizumab relative dose intensity (RDI) and first-line treatment outcomes in advanced epithelial ovarian cancer. METHODS We retrospectively analyzed 72 patients treated with first-line bevacizumab plus paclitaxel-platinum chemotherapy between January 2019 and September...